Clinical Trials Directory

Trials / Completed

CompletedNCT04551781

Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis

Short Term Low Dose Corticosteroids for Management of Post Covid-19 Pulmonary Fibrosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
450 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized controlled trial to study the efficacy of low dose steroid for 14 days in the treatment of post-covid-19 lung infiltrates

Detailed description

: the study included patients with COVID-19 diagnosis with a positive nasopharyngeal swab, they were discharged from quarantine hospitals after 2 Polymerase chain reaction (PCR) swab negative for COVID-19, and have persistent radiological changes in follow-up chest computed tomography (CT) chest, patients with normal CT chest at discharge, patients on chemotherapy, patients \<18years old, patients with known interstitial lung disease and patients with rheumatoid arthritis or systemic lupus erythematosus were excluded from the study. Study patients were randomly assigned to either steroid group or control group and were followed up for 14 days, and CT chest was done at end of 14 days and was evaluated by a radiologist how was blinded for study arm, Ct chest was graded either very minimal infiltrates including reticular shadows, hallow sign, and ground glass s (GGO), infiltrates \<25%, and infiltrates \>25%. The steroid group received 20 mg/day prednisolone for 14 days in addition to symptomatic treatment; the control group received symptomatic treatment without steroids Data collected included patient demographics, symptoms, and its duration at baseline, CBC, Ferritin and D-dime, CT chest at discharge, and after 14 days of inclusions in the study.

Conditions

Interventions

TypeNameDescription
DRUG20 Mg Prednisone for 14 days20 Mg Prednisone for 14 days
DRUGcontrolsymptomatic ttt

Timeline

Start date
2020-04-01
Primary completion
2020-07-30
Completion
2020-07-30
First posted
2020-09-16
Last updated
2020-09-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04551781. Inclusion in this directory is not an endorsement.